Hormonal
GLP-1 receptor agonists (exenatide, liraglutide, albiglutide, dulaglutide, lixisenatide) effectively lower hemoglobin A1C and promote weight loss in patients with type 2 diabetes, offering advantages over sulfonylureas, thiazolidinediones, and insulin regarding weight gain and hypoglycemia risk.
If you have type 2 diabetes and struggle with weight gain or hypoglycemia from other meds, GLP-1 agonists are a strong option. They help lower blood sugar and promote weight loss. Start with a low dose to avoid stomach issues, and consider once-weekly versions if you dislike daily injections. Always combine with diet and exercise.
GLP-1 receptor agonists represent a unique approach to the treatment of diabetes, with benefits extending outside glucose control, including positive effects on weight, blood pressure, cholesterol levels, and beta-cell function... The most common adverse effects seen with GLP-1 therapy include nausea, vomiting, and injection-site reactions.
Why this rating
The paper is a clinical review citing multiple randomized controlled trials (RCTs) and phase 3 studies (e.g., LEAD-6, AWARD studies).
Source
A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond
Lalita Prasad‐Reddy et al. · Drugs in Context · 2015
DOI 10.7573/dic.212283
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →